mn-001
Generic: tipelukast·Code: MN-001
mn-001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| MEDICINOVA INC (MNOV) | Phase 2 |
Clinical Trials (1)
A Randomized, Placebo-Controlled, Double-Blind Six Month Study Followed by an Open-Label Extension Phase to Evaluate the Efficacy, Safety and Tolerability of MN-001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Frequently asked questions
Who is developing mn-001?
mn-001 is being developed by MEDICINOVA INC.
How many clinical trials involve mn-001?
BioSniper tracks 1 clinical trial involving mn-001.
Get deeper analysis on mn-001
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis